Prostate-cancer-targeted N-(2-hydroxypropyl)methacrylamide copolymer/docetaxel conjugates.
about
HPMA copolymer-based combination therapy toxic to both prostate cancer stem/progenitor cells and differentiated cells induces durable anti-tumor effects.Smart linkers in polymer-drug conjugates for tumor-targeted delivery.Inhibition of influenza virus in vivo by siRNA delivered using ABA triblock copolymer synthesized by reversible addition-fragmentation chain-transfer polymerization.Spacer length impacts the efficacy of targeted docetaxel conjugates in prostate-specific membrane antigen expressing prostate cancer
P2860
Prostate-cancer-targeted N-(2-hydroxypropyl)methacrylamide copolymer/docetaxel conjugates.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Prostate-cancer-targeted N-(2- ...... opolymer/docetaxel conjugates.
@ast
Prostate-cancer-targeted N-(2- ...... opolymer/docetaxel conjugates.
@en
type
label
Prostate-cancer-targeted N-(2- ...... opolymer/docetaxel conjugates.
@ast
Prostate-cancer-targeted N-(2- ...... opolymer/docetaxel conjugates.
@en
prefLabel
Prostate-cancer-targeted N-(2- ...... opolymer/docetaxel conjugates.
@ast
Prostate-cancer-targeted N-(2- ...... opolymer/docetaxel conjugates.
@en
P2093
P2860
P356
P1476
Prostate-cancer-targeted N-(2- ...... opolymer/docetaxel conjugates.
@en
P2093
Huaizhong Pan
Jindřich Kopeček
Monika Sima
Patrick Bühler
Pavla Kopečková
Philipp Wolf
Ursula Elsässer-Beile
P2860
P304
P356
10.1002/MABI.201100340
P577
2012-03-01T00:00:00Z